Montréal Invivo
  • Business Directory
  • Newsletters
  • Events
  • News
  • FR
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Digital health
      • Artificial Intelligence
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become Partner
  • Home
  • Business Directory
  • Newsletters
  • Events
  • News
  • Montreal InVivo
    • Partners
    • Press releases
    • Job Opportunities
    • About
    • Governance
    • Team
  • The LSHT ecosystem
    • Portrait of the sector
      • Industry Snapshot
      • Portrait of the workforce and the next generation
      • Discover the jobs of the future
    • Niches of excellence
      • Digital health
      • Artificial Intelligence
      • Health technologies
      • Oncology
      • Personnalized Healthcare
      • Rare diseases
      • Biomanufacturing
      • RNA Therapies
      • Cellular Therapy
    • Entrepreneurial spotlight videos
  • Our actions
    • Studies and Analyses: Business Intelligence on the Sector
    • Mobilization
    • Project committees
    • Training and services
  • Our resources
  • Become Partner
  • FRANçAIS
Back to documents
Briefs and consultations

Presentation of the Rare Disease Strategic Action Plan 2022

18 May 2022

Montreal InVivo has created a Rare Disease Project Committee, representing the entire ecosystem, to propose a national plan! The presentation highlights the need for rare disease patients, Quebecers and those affected by a rare disease to have rapid and optimal access to therapeutic and diagnostic innovations; and 2) To improve the competitiveness of the Quebec innovation ecosystem.

Click here to see the Rare Disease Strategic Action Plan !

Maladie rares - présentation ANG-VF - 3,74 MB
Documents

We suggest

10 Sep 2025
Studies and analysis

Cartographie du financement non dilutif disponible au Québec pour les compagnies en SVTS

Veuillez noter que nos cartographies sont mises à jour chaque mois. La dernière mise à jour date du 30 septembre 2025. Pour toute suggestion de modification, écrire à agour...

09 Sep 2025
Studies and analysis

Overview of Venture Capital Funding for LSHT Companies in Quebec

Please note that our mapping is updated monthly. The last update was on September 30, 2025. For any suggestions for changes, please write to agouronnec@montreal-invivo.com

10 Sep 2025
Studies and analysis

Mapping of non-dilutive financing available in Quebec for LSHT companies

Please note that our mapping is updated monthly. The last update was on September 30, 2025. For any suggestions for changes, please write to agouronnec@montreal-invivo.com

Subscribe to our newsletters

Stay informed of the industry’s breaking news by subscribing to our different type of newsletters

I want to subscribe
Montréal Invivo
  • Press releases
  • Newsletters
  • Contact us
  • Privacy policy
514 987-9377
info@montreal-invivo.com
3650 rue Saint-Urbain, bureau 711, Montréal (Québec), H2X 2P2
All rights reserved 2026 Montréal Invivo Creation and Web Design PAR Design
×
facebook twitter X home map-marker map refresh clock chevron-left chevron-up chevron-right chevron-down angle-left angl-right angle-up angle-down angle-left angle-right angle-up angle-down fax phone book search envelope-o lock print play book calendar user share2 linkedin cloud-download youtube-play spinner calendar doc pdf svg